These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhaled insulins. Ghosh S; Collier A Postgrad Med J; 2007 Mar; 83(977):178-81. PubMed ID: 17344572 [TBL] [Abstract][Full Text] [Related]
3. Inhaled human insulin (Exubera): clinical profile and patient considerations. Barnett AH; Bellary S Vasc Health Risk Manag; 2007; 3(1):83-91. PubMed ID: 17583178 [TBL] [Abstract][Full Text] [Related]
4. Exubera(®) (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetes. Profit L Core Evid; 2005; 1(2):89-101. PubMed ID: 22500147 [TBL] [Abstract][Full Text] [Related]
5. Different routes of insulin administration do not influence serum free thiols in type 1 diabetes mellitus. van Dijk PR; Waanders F; Logtenberg SJJ; Groenier KH; Vriesendorp TM; Kleefstra N; van Goor H; Bilo HJG Endocrinol Diabetes Metab; 2019 Oct; 2(4):e00088. PubMed ID: 31592137 [TBL] [Abstract][Full Text] [Related]
6. A Review: The Prospect of Inhaled Insulin Therapy via Vibrating Mesh Technology to Treat Diabetes. Cunningham SM; Tanner DA Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32785196 [No Abstract] [Full Text] [Related]
7. Metabolic hormones, apolipoproteins, adipokines, and cytokines in the alveolar lining fluid of healthy adults: compartmentalization and physiological correlates. Mendivil CO; Koziel H; Brain JD PLoS One; 2015; 10(4):e0123344. PubMed ID: 25848795 [TBL] [Abstract][Full Text] [Related]
8. Inhaled insulin is associated with prolonged enhancement of glucose disposal in muscle and liver in the canine. Edgerton DS; Cherrington AD; Neal DW; Scott M; Lautz M; Brown N; Petro J; Hobbs CH; Leach C; Del Parigi A; Strack TR J Pharmacol Exp Ther; 2009 Mar; 328(3):970-5. PubMed ID: 19098161 [TBL] [Abstract][Full Text] [Related]
9. New ways of insulin delivery. Heinemann L Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662 [TBL] [Abstract][Full Text] [Related]
10. Inhaled human insulin (Exubera): a review of its use in adult patients with diabetes mellitus. Dunn C; Curran MP Drugs; 2006; 66(7):1013-32. PubMed ID: 16740022 [TBL] [Abstract][Full Text] [Related]
11. Trough insulin levels in bronchoalveolar lavage following inhaled human insulin (Exubera) in patients with diabetes mellitus. Mendivil CO; Teeter JG; Finch GL; Schwartz PF; Riese RJ; Brain JD Diabetes Technol Ther; 2012 Jan; 14(1):50-8. PubMed ID: 21875362 [TBL] [Abstract][Full Text] [Related]
12. Randomized study to characterize glycemic control and short-term pulmonary function in patients with type 1 diabetes receiving inhaled human insulin (exubera). Norwood P; Dumas R; Cefalu W; Yale JF; England R; Riese R; Teeter J J Clin Endocrinol Metab; 2007 Jun; 92(6):2211-4. PubMed ID: 17003088 [TBL] [Abstract][Full Text] [Related]
13. Assessment of long-term immunological and pulmonary safety of inhaled human insulin with up to 24 months of continuous therapy. Cefalu WT; Bohannon NJ; Edwin Fineberg S; Teeter JG; Schwartz PF; Reis JM; Krasner AS Curr Med Res Opin; 2008 Nov; 24(11):3073-83. PubMed ID: 18828959 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial. Rosenstock J; Cefalu WT; Hollander PA; Klioze SS; Reis J; Duggan WT Diabetes Technol Ther; 2009 Nov; 11(11):697-705. PubMed ID: 19905885 [TBL] [Abstract][Full Text] [Related]
15. Titration of inhaled human insulin (Exubera) in a treat-to-target regimen for patients with type 2 diabetes. Hollander PA; Cefalu WT; Mitnick M; Lawrence D; Rosenstock J Diabetes Technol Ther; 2010 Mar; 12(3):185-91. PubMed ID: 20151768 [TBL] [Abstract][Full Text] [Related]